Cargando…

Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants

Mostrar otras versiones (1)

Vaccines that induce potent neutralizing antibody (NAb) responses against emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are essential for combating the coronavirus disease 2019 (COVID-19) pandemic. We demonstrated that mouse plasma induced by self-assembling prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yi-Nan, Paynter, Jennifer, Sou, Cindy, Fourfouris, Tatiana, Wang, Ying, Abraham, Ciril, Ngo, Timothy, Zhang, Yi, He, Linling, Zhu, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for the Advancement of Science 2021
Materias:	Biomedicine and Life Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528426/ https://www.ncbi.nlm.nih.gov/pubmed/34669468 http://dx.doi.org/10.1126/sciadv.abj3107

Ejemplares similares

Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants
por: Zhang, Yi-Nan, et al.
Publicado: (2021)

Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody
por: Kumar, Sanjeev, et al.
Publicado: (2022)

Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates
por: He, Linling, et al.
Publicado: (2021)

Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates
por: He, Linling, et al.
Publicado: (2021)

Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice
por: Puente-Massaguer, Eduard, et al.
Publicado: (2023)

EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination
por: Krug, Peter W., et al.
Publicado: (2023)

Defective import of mitochondrial metabolic enzyme elicits ectopic metabolic stress
por: Nishio, Kazuya, et al.
Publicado: (2023)

Xeno interactions between MHC-I proteins and molecular chaperones enable ligand exchange on a broad repertoire of HLA allotypes
por: Sun, Yi, et al.
Publicado: (2023)

Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo
por: Torchia, James A., et al.
Publicado: (2022)

Broad responses to chemical adducts shape the natural antibody repertoire in early infancy
por: Mashiko, Shunya, et al.
Publicado: (2023)

Multiepitope supramolecular peptide nanofibers eliciting coordinated humoral and cellular antitumor immune responses
por: Wu, Yaoying, et al.
Publicado: (2022)

Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies
por: Kudlacek, Stephan T., et al.
Publicado: (2021)

Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodies
por: Wrapp, Daniel, et al.
Publicado: (2022)

A naturally arising broad and potent CD4-binding site antibody with low somatic mutation
por: Barnes, Christopher O., et al.
Publicado: (2022)

Structural basis for HCMV Pentamer receptor recognition and antibody neutralization
por: Kschonsak, Marc, et al.
Publicado: (2022)

Transplanted organoids empower human preclinical assessment of drug candidate for the clinic
por: Westerling-Bui, Amy D., et al.
Publicado: (2022)

Phylogenetic identification of influenza virus candidates for seasonal vaccines
por: Hayati, Maryam, et al.
Publicado: (2023)

Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
por: Lee, Wen Shi, et al.
Publicado: (2023)

PTPN2 elicits cell autonomous and non–cell autonomous effects on antitumor immunity in triple-negative breast cancer
por: Goh, Pei Kee, et al.
Publicado: (2022)

Self-assembling peptide nanofiber HIV vaccine elicits robust vaccine-induced antibody functions and modulates Fc glycosylation
por: Chen, Jui-Lin, et al.
Publicado: (2022)

SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques
por: Dalvie, Neil C., et al.
Publicado: (2022)

Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody
por: Callaway, Heather M., et al.
Publicado: (2022)

Identification of immune-related candidate biomarkers in plasma of patients with sporadic vestibular schwannoma
por: Vasilijic, Sasa, et al.
Publicado: (2023)

Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response
por: Dickey, Thayne H., et al.
Publicado: (2022)

Repetitive mRNA vaccination is required to improve the quality of broad-spectrum anti–SARS-CoV-2 antibodies in the absence of CXCL13
por: Azarias Da Silva, Marne, et al.
Publicado: (2023)

Design of a pan-betacoronavirus vaccine candidate through a phylogenetically informed approach
por: Lewitus, Eric, et al.
Publicado: (2023)

Identification of procathepsin L (pCTS-L)–neutralizing monoclonal antibodies to treat potentially lethal sepsis
por: Zhu, Cassie Shu, et al.
Publicado: (2023)

Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain
por: Gray, Matthew D., et al.
Publicado: (2022)

Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target
por: Shi, Jiandong, et al.
Publicado: (2023)

Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies
por: Hanke, Leo, et al.
Publicado: (2022)

Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors
por: Moghadasi, Seyed Arad, et al.
Publicado: (2023)

A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19
por: Fava, Vinicius M., et al.
Publicado: (2022)

Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission
por: Goyal, Ashish, et al.
Publicado: (2022)

Intrinsic B cell TLR-BCR linked coengagement induces class-switched, hypermutated, neutralizing antibody responses in absence of T cells
por: Rivera, Carlos E., et al.
Publicado: (2023)

CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes
por: Onodera, Taishi, et al.
Publicado: (2023)

Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor
por: Chia, Wan Ni, et al.
Publicado: (2023)

Sequence variants affecting voice pitch in humans
por: Gisladottir, Rosa S., et al.
Publicado: (2023)

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities
por: Chen, Yaozong, et al.
Publicado: (2022)

A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering
por: Zhu, Jingen, et al.
Publicado: (2021)

A universal influenza mRNA vaccine candidate boosts T cell responses and reduces zoonotic influenza virus disease in ferrets
por: van de Ven, Koen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e90vib76b5nifcncuicss4t7dg